TY - JOUR
T1 - Internalization of p5314-29 peptide amphiphiles and subsequent endosomal disruption results in SJSA-1 cell death
AU - Missirlis, Dimitris
AU - Krogstad, Daniel V.
AU - Tirrell, Matthew
PY - 2010/12/6
Y1 - 2010/12/6
N2 - In vivo peptide inhibition of tumor suppressor p53 binding to the protein MDM2 is hampered by inefficient delivery of the peptide. Our approach to couple a hydrophobic lipid-like tail on the inhibitory peptide p5314-29 allowed its intracellular delivery in vitro, in a panel of different cell lines. The constructed chimeric molecules, termed peptide amphiphiles, further self-assembled into supramolecular structures, identified as elongated wormlike micelles. Internalization of peptides occurred following micelle disassembly, partly via clathrin-mediated endocytosis of monomers. Incubation of SJSA-1 cells in hypertonic culture media, aimed to disrupt endocytic vesicles, resulted in peptide amphiphile-mediated cell death. Our results provide the basis for the construction of novel therapeutic supramolecular nanoparticles and suggest hydrophobic modification of peptides as a promising strategy for enhancing delivery of impermeable peptides.
AB - In vivo peptide inhibition of tumor suppressor p53 binding to the protein MDM2 is hampered by inefficient delivery of the peptide. Our approach to couple a hydrophobic lipid-like tail on the inhibitory peptide p5314-29 allowed its intracellular delivery in vitro, in a panel of different cell lines. The constructed chimeric molecules, termed peptide amphiphiles, further self-assembled into supramolecular structures, identified as elongated wormlike micelles. Internalization of peptides occurred following micelle disassembly, partly via clathrin-mediated endocytosis of monomers. Incubation of SJSA-1 cells in hypertonic culture media, aimed to disrupt endocytic vesicles, resulted in peptide amphiphile-mediated cell death. Our results provide the basis for the construction of novel therapeutic supramolecular nanoparticles and suggest hydrophobic modification of peptides as a promising strategy for enhancing delivery of impermeable peptides.
UR - http://www.scopus.com/inward/record.url?scp=78649965846&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78649965846&partnerID=8YFLogxK
U2 - 10.1021/mp100193h
DO - 10.1021/mp100193h
M3 - Article
C2 - 20822110
AN - SCOPUS:78649965846
SN - 1543-8384
VL - 7
SP - 2173
EP - 2184
JO - Molecular pharmaceutics
JF - Molecular pharmaceutics
IS - 6
ER -